ZURICH (Reuters) - The U.S. Food and Drug Administration has classified a recall of Synthes’ Synex II Central Body components as Class I, meaning the products could pose an imminent health hazard.
Swiss medical device company Synthes voluntarily recalled all Synex II Central Body components on September 14 following six adverse event reports.
“Synthes advises that surgeons and hospitals in possession of the subject devices must stop implanting them immediately,” the company said in a statement.
The recall involves part numbers 04.808.001-011, Synex II Central Body, Titanium.
Writing by Lisa Jucca; Editing by Jon Loades-Carter
Our Standards: The Thomson Reuters Trust Principles.